11305707

Source:http://linkedlifedata.com/resource/pubmed/id/11305707

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0006012, umls-concept:C0008976, umls-concept:C0439611, umls-concept:C0886883
pubmed:issue	3
pubmed:dateCreated	2001-4-17
pubmed:abstractText	Borderline personality disorder is characterized by affective instability, impulsivity, and aggression and is associated with considerable morbidity and mortality. Since anticonvulsant agents may be helpful in such symptomatology, we compared divalproex sodium with placebo in patients with borderline personality disorder.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/1 RO3 MH58168-01A1, http://linkedlifedata.com/resource/pubmed/grant/5 MO1 RR00071
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7801243
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Anticonvulsants, http://linkedlifedata.com/resource/pubmed/chemical/Placebos, http://linkedlifedata.com/resource/pubmed/chemical/Valproic Acid
pubmed:status	MEDLINE
pubmed:month	Mar
pubmed:issn	0160-6689
pubmed:author	pubmed-author:AllenAA, pubmed-author:BienstockC ACA, pubmed-author:GrossmanRR, pubmed-author:HollanderEE, pubmed-author:LopezR PRP, pubmed-author:MerkatzLL, pubmed-author:SieverL JLJ, pubmed-author:SteinD JDJ
pubmed:issnType	Print
pubmed:volume	62
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	199-203
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:11305707-Adolescent, pubmed-meshheading:11305707-Adult, pubmed-meshheading:11305707-Aggression, pubmed-meshheading:11305707-Ambulatory Care, pubmed-meshheading:11305707-Anticonvulsants, pubmed-meshheading:11305707-Borderline Personality Disorder, pubmed-meshheading:11305707-Comorbidity, pubmed-meshheading:11305707-Depressive Disorder, pubmed-meshheading:11305707-Double-Blind Method, pubmed-meshheading:11305707-Female, pubmed-meshheading:11305707-Humans, pubmed-meshheading:11305707-Male, pubmed-meshheading:11305707-Middle Aged, pubmed-meshheading:11305707-Patient Dropouts, pubmed-meshheading:11305707-Personality Inventory, pubmed-meshheading:11305707-Placebos, pubmed-meshheading:11305707-Psychiatric Status Rating Scales, pubmed-meshheading:11305707-Severity of Illness Index, pubmed-meshheading:11305707-Treatment Outcome, pubmed-meshheading:11305707-Valproic Acid
pubmed:year	2001
pubmed:articleTitle	A preliminary double-blind, placebo-controlled trial of divalproex sodium in borderline personality disorder.
pubmed:affiliation	Department of Psychiatry, Mount Sinai School of Medicine, New York, NY 10029-6574, USA. eric.hollander@mssm.edu
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Research Support, Non-U.S. Gov't